Melanoma risk declines with self-exams plus doctor visit

August 24, 2012
Melanoma risk declines with self-exams plus doctor visit
Risk of deeper melanomas is reduced with self-examination of the skin one to 11 times a year, according to a study published online Aug. 16 in the British Journal of Dermatology.

(HealthDay)—Risk of deeper melanomas is reduced with self-examination of the skin one to 11 times a year, according to a study published online Aug. 16 in the British Journal of Dermatology.

Linda J. Titus, Ph.D., from the Dartmouth-Hitchcock Medical Center in Lebanon, N.H., and colleagues analyzed data from a population-based case-control study (423 cases and 678 controls) to assess recent skin self-examination in relation to self-detection, risk, and tumor depth.

The researchers found that skin self-examination conducted one to 11 times during a recent year was associated with a possible decrease in melanoma risk (odds ratio [OR], 0.74). For those who conducted skin self-examination and saw a doctor, the melanoma risk was significantly decreased (OR, 0.54). Among those patients with melanoma, those who examined their skin were twice as likely to self-detect the melanoma (OR, 2.23), but self-detection was not associated with shallower tumors. For those who conducted skin self-examination one to 11 times during a recent year, tumor depth was significantly reduced (OR, 0.39), but was not influenced by seeing a doctor or by conducting skin self-examination combined with seeing a doctor.

"Risk of a deeper and possibly risk of melanoma were reduced by self-examination one to 11 times annually," the authors write.

Explore further: Melanoma screening by physicians associated with finding more cancers than patient self-detection

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Melanoma screening by physicians associated with finding more cancers than patient self-detection

July 18, 2011
Physician-based screening for melanoma is associated with higher rates of physician-detected melanoma and detection of thinner melanoma, according to a report published Online First today by Archives of Dermatology, one of ...

Risk of second primary melanoma up in pediatric patients

June 28, 2012
(HealthDay) -- Pediatric patients diagnosed with an invasive cutaneous melanoma have nearly double the relative risk of developing a subsequent primary melanoma, compared with adults, according to a study published online ...

People with Parkinson's disease may have double the risk for melanoma

June 6, 2011
An analysis of several studies shows that people with Parkinson's disease have a significantly higher risk of melanoma, the most dangerous type of skin cancer and the leading cause of death from skin diseases. The research ...

Recommended for you

New therapeutic approach for difficult-to-treat subtype of ovarian cancer identified

July 24, 2017
A potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer has been discovered by Wistar scientists. The findings were published online in Nature Cell Biology.

Immune cells the missing ingredient in new bladder cancer treatment

July 24, 2017
New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer.

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.